Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution
Clarivate (NYSE: CLVT) has launched DRG Commercial Analytics 360, a new solution designed to help medtech companies enhance their commercial strategies through advanced data analytics. The platform combines Procedure Finder's search capabilities with Clarivate's provider and affiliations network to deliver comprehensive real-world intelligence.
The solution offers several key features:
- Integrated healthcare provider data and analytics for understanding patient treatment patterns and network affiliations
- De-duplicated market segments for accurate procedure volume tracking
- 360-degree market visibility with modularized claims and code groupings
- Expert-led data intelligence backed by medtech and healthcare specialists
The platform aims to help medtech companies optimize targeting, strategic planning, and patient access while enabling data-driven decision-making across commercial organizations.
Clarivate (NYSE: CLVT) ha lanciato DRG Commercial Analytics 360, una nuova soluzione pensata per aiutare le aziende medtech a migliorare le loro strategie commerciali attraverso l’analisi avanzata dei dati. La piattaforma unisce le capacità di ricerca di Procedure Finder con la rete di fornitori e affiliazioni di Clarivate per offrire un’intelligenza completa basata su dati reali.
La soluzione presenta diverse funzionalità chiave:
- Dati integrati sui fornitori sanitari e analisi per comprendere i modelli di trattamento dei pazienti e le affiliazioni di rete
- Segmenti di mercato depurati da duplicati per un monitoraggio preciso dei volumi di procedure
- Visibilità a 360 gradi del mercato con raggruppamenti modulari di reclami e codici
- Intelligenza dati guidata da esperti supportata da specialisti medtech e sanitari
La piattaforma mira a supportare le aziende medtech nell’ottimizzazione del targeting, nella pianificazione strategica e nell’accesso ai pazienti, favorendo decisioni basate sui dati in tutte le organizzazioni commerciali.
Clarivate (NYSE: CLVT) ha lanzado DRG Commercial Analytics 360, una nueva solución diseñada para ayudar a las empresas medtech a mejorar sus estrategias comerciales mediante análisis avanzados de datos. La plataforma combina las capacidades de búsqueda de Procedure Finder con la red de proveedores y afiliaciones de Clarivate para ofrecer una inteligencia integral basada en datos reales.
La solución ofrece varias características clave:
- Datos integrados de proveedores de salud y análisis para comprender los patrones de tratamiento de pacientes y las afiliaciones en la red
- Segmentos de mercado depurados para un seguimiento preciso del volumen de procedimientos
- Visibilidad del mercado a 360 grados con agrupaciones modulares de reclamos y códigos
- Inteligencia de datos guiada por expertos respaldada por especialistas en medtech y salud
La plataforma busca ayudar a las empresas medtech a optimizar el enfoque, la planificación estratégica y el acceso de los pacientes, facilitando la toma de decisiones basada en datos en todas las organizaciones comerciales.
Clarivate (NYSE: CLVT)가 DRG Commercial Analytics 360을 출시했습니다. 이 새로운 솔루션은 메드텍 기업들이 고급 데이터 분석을 통해 상업 전략을 강화할 수 있도록 설계되었습니다. 이 플랫폼은 Procedure Finder의 검색 기능과 Clarivate의 제공자 및 제휴 네트워크를 결합하여 포괄적인 실제 데이터 기반 인텔리전스를 제공합니다.
이 솔루션은 다음과 같은 주요 기능을 제공합니다:
- 환자 치료 패턴과 네트워크 제휴를 이해하기 위한 통합 의료 제공자 데이터 및 분석
- 정확한 시술량 추적을 위한 중복 제거된 시장 세그먼트
- 모듈화된 청구 및 코드 그룹을 통한 360도 시장 가시성
- 메드텍 및 의료 전문가가 지원하는 전문가 주도 데이터 인텔리전스
이 플랫폼은 메드텍 기업들이 타겟팅, 전략 기획, 환자 접근성을 최적화하고, 상업 조직 전반에 걸쳐 데이터 기반 의사결정을 가능하게 하는 것을 목표로 합니다.
Clarivate (NYSE : CLVT) a lancé DRG Commercial Analytics 360, une nouvelle solution conçue pour aider les entreprises medtech à améliorer leurs stratégies commerciales grâce à l’analyse avancée des données. La plateforme combine les capacités de recherche de Procedure Finder avec le réseau de fournisseurs et d’affiliations de Clarivate pour fournir une intelligence complète basée sur des données réelles.
La solution offre plusieurs fonctionnalités clés :
- Données intégrées des prestataires de soins et analyses pour comprendre les schémas de traitement des patients et les affiliations réseau
- Segments de marché dédupliqués pour un suivi précis du volume des procédures
- Visibilité à 360 degrés du marché avec des regroupements modulaires de réclamations et de codes
- Intelligence des données pilotée par des experts, soutenue par des spécialistes medtech et santé
La plateforme vise à aider les entreprises medtech à optimiser le ciblage, la planification stratégique et l’accès aux patients, tout en favorisant une prise de décision basée sur les données dans l’ensemble des organisations commerciales.
Clarivate (NYSE: CLVT) hat DRG Commercial Analytics 360 eingeführt, eine neue Lösung, die Medtech-Unternehmen dabei unterstützt, ihre kommerziellen Strategien durch fortschrittliche Datenanalysen zu verbessern. Die Plattform kombiniert die Suchfunktionen von Procedure Finder mit dem Anbieter- und Affiliationsnetzwerk von Clarivate, um umfassende Echtzeit-Intelligenz zu liefern.
Die Lösung bietet mehrere wichtige Funktionen:
- Integrierte Gesundheitsanbieter-Daten und Analysen zum Verständnis von Behandlungsmustern und Netzwerkzugehörigkeiten
- Bereinigte Marktsegmente zur genauen Verfolgung des Verfahrensvolumens
- 360-Grad-Markteinblick mit modularen Abrechnungs- und Codegruppen
- Expertengeführte Datenintelligenz, unterstützt von Medtech- und Gesundheitsfachleuten
Die Plattform zielt darauf ab, Medtech-Unternehmen bei der Optimierung von Zielgruppenansprache, strategischer Planung und Patientenzugang zu unterstützen und datenbasierte Entscheidungsfindung in kommerziellen Organisationen zu ermöglichen.
- Launch of new analytics product expanding Clarivate's medtech solutions portfolio
- Platform combines existing Procedure Finder capabilities with provider network data
- Potential for increased revenue through enhanced commercial targeting capabilities
- None.
Insights
Clarivate's new analytics platform integrates provider data with procedure insights, enabling targeted commercial strategies for medtech companies.
Clarivate's newly launched DRG Commercial Analytics 360 represents a strategic enhancement to their medtech intelligence offerings. The solution integrates two core data assets—their Procedure Finder capabilities and provider affiliation networks—creating a unified analytics platform specifically designed for medical device commercial teams.
The product architecture addresses several key technical challenges in medtech analytics. First, by de-duplicating procedure codes while maintaining clinical relevance, it solves the persistent problem of market sizing accuracy that has plagued the sector. Second, its modularized approach to claims data enables flexible analysis across different market segments and care settings, critical for companies navigating the increasingly fragmented healthcare delivery landscape.
What distinguishes this platform technically is its focus on integration across commercial functions rather than siloed analytics. By connecting provider intelligence with procedure data, it creates a digital thread through targeting, strategic planning, and market access workflows—enabling consistent data-driven decision making across departments that typically operate with different information sets.
The testimonial from Bioventus highlights a key value proposition: transforming data into actionable strategy rather than simply reporting market information. This suggests the platform includes visualization and insight generation capabilities beyond raw data delivery.
For Clarivate, this launch represents continued execution on their sectoral analytics strategy, leveraging their healthcare data assets to create specialized intelligence products for vertical industries. While incrementally positive for their product portfolio, it appears to be an evolution of existing capabilities rather than a revolutionary new offering.
Clarivate's medtech analytics platform addresses critical commercial challenges by connecting procedure data with provider networks for targeted market engagement.
Clarivate's DRG Commercial Analytics 360 addresses a significant pain point in the medtech commercial landscape: the disconnect between procedure-level market data and the complex provider ecosystem. As hospital systems continue consolidating and procedures shift between care settings, medtech companies struggle to accurately identify and engage key decision-makers.
The platform's emphasis on de-duplicated market segments is particularly relevant as medtech companies face growing challenges with procedure classification. Multiple billing codes often represent similar procedures, making accurate market sizing difficult. By applying expert-led categorization, the solution promises to deliver clearer market visibility—essential for resource allocation in the competitive medtech space.
What's notable is the platform's focus on tracking procedures across different care settings, including ambulatory surgery centers (ASCs). This capability addresses the accelerating shift of many procedures from inpatient to outpatient settings, a trend reshaping medtech commercial strategy as companies must engage with entirely different economic buyers and value propositions.
The Bioventus testimonial highlights a critical shift in commercial approach: moving from competitor-focused tactics to more strategic conversations with both clinicians and healthcare business leaders. This reflects the evolving selling environment in medtech, where clinical performance must be paired with economic value narratives.
For medtech organizations, solutions that connect procedure volumes with provider networks offer tangible commercial advantages through more efficient resource allocation and targeted engagement strategies. However, the impact will vary significantly based on therapeutic area and company size, with larger organizations potentially seeing incremental efficiency gains rather than transformative commercial outcomes.
New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations
Tailored for the medtech sector, the platform combines the robust search capabilities of Procedure Finder with the extensive Clarivate provider and affiliations network. It delivers real-world, data-driven intelligence, enabling medtech companies to optimize strategic planning, field sales performance and market execution.
Juliane Ray, Vice President, Product Management, Medtech, Life Sciences & Healthcare, Clarivate, said: "DRG Commercial Analytics 360 was purpose-built to help medtech companies translate real-world data into smarter, more agile commercial strategies. By enabling precise omnichannel targeting, seamless integration and intelligent bundling, the platform provides the accuracy and granularity needed to navigate today's complex provider landscape. With insights mastered at the market segment level, our customers can uncover new opportunities and make confident, data-driven decisions that advance both business goals and patient access."
Theo McCormick, Senior Manager Pricing & Analytics, Bioventus, Inc., said: "Understanding the data has helped to shape our strategy, instead of chasing competitors, we're now looking at clinicians differently. The data is helping to change our conversations with physicians to include the business leaders of healthcare systems."
To meet the evolving demands of complex targeting in medtech, DRG Commercial Analytics 360 delivers a suite of capabilities that enable smarter, data-driven decisions across the commercial organization:
- Actionable Intelligence: Integrated healthcare provider data and analytics offer clear, tailored insights into who is treating targeted patients, their network affiliations, and where procedures are performed—across hospitals, ambulatory surgery centers, and other care settings.
- Accurate, De-duplicated Market Segments: By categorizing procedures by type and eliminating code-level duplication, the platform ensures a reliable, detailed view of procedure volume and flow across the U.S. market.
- 360˚ Market Visibility: Modularized claims and code groupings are aligned with precise market definitions to support accurate market sizing and informed resource allocation.
- Expert-Led Data Intelligence: Backed by in-house medtech, medical coding, and
U.S. healthcare expertise, Clarivate data scientists apply tailored extrapolation methodologies to surface nuanced insights across market segments.
The Clarivate medtech team partners with medical device companies and distributors to fully harness the value of DRG Commercial Analytics 360—whether building national strategy or optimizing field sales planning. To learn more about DRG Commercial Analytics 360, visit here.
About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com
Media Contact:
Luna Ivkovic
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-launches-drg-commercial-analytics-360-enabling-medtech-companies-to-advance-commercial-strategy-and-execution-302434609.html
SOURCE Clarivate Plc
FAQ
What features does Clarivate's DRG Commercial Analytics 360 offer to medtech companies?
How does DRG Commercial Analytics 360 benefit medtech sales teams?
What types of healthcare data does CLVT's new analytics platform track?
How does DRG Commercial Analytics 360 handle market segmentation?
